Riskpilot← Back to searchSign inGet full accessTJ-Imaging ApS
APSActiveCVR 37413097Troldholm 5Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20167 employees
Revenue 2024
DKK 6,3M
-11% vs 2023
EBITDA margin
-33.1%
-271% vs 2023
Equity ratio
-14.8%
Financial strength
Net profit 2024
DKK -2,2M
-369% vs 2023
| Revenue | DKK 6,3M | -11% |
| EBITDA | DKK -2,1M | -271% |
| Net profit | DKK -2,2M | -369% |
| Total assets | DKK 6,9M | -34% |
| Equity | DKK -1M | -186% |
| Employees | 7 | — |
Legal name
TJ-Imaging ApS
CVR number
37413097
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. februar 2016
Share capital
DKK 50.000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af direktionen.
Company purpose
Virksomhedens formål er handel med medicinudstyr samt anden dermed efter direktionens skøn beslægtet virksomhed.
Address
Troldholm 5
Phone
+4553715520
Email
tbo@tj-imaging.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.003 | 1.683 | 2.497 | 4.156 | 5.901 | 4.544 | 3.007 | 7.081 | 6.292 |
| Staff expenses | -2.141 | -2.123 | -3.388 | -3.425 | -4.472 | -4.768 | -2.456 | -5.859 | -8.377 |
| EBITDA | 861 | -440 | -891 | 731 | 1.429 | -224 | 552 | 1.222 | -2.085 |
| Depreciation & amort. | -35 | -17 | -26 | -26 | -17 | -25 | -13 | -25 | -32 |
| EBIT | 827 | -457 | -917 | 705 | 1.412 | -249 | 538 | 1.197 | -2.117 |
| Net financials | -146 | -43 | -205 | -192 | -334 | -195 | -94 | -158 | -94 |
| Profit before tax | 681 | -500 | -1.122 | 513 | 1.079 | -444 | 444 | 1.039 | -2.211 |
| Tax | 161 | -104 | -241 | 124 | 258 | -82 | 105 | 219 | 1 |
| Net profit | 520 | -396 | -881 | 389 | 821 | -361 | 340 | 821 | -2.211 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3.349 | 4.923 | 3.713 | 5.531 | 5.576 | 5.164 | 7.548 | 10.474 | 6.878 |
| Equity | 570 | 63 | -818 | -429 | 392 | 31 | 370 | 1.191 | -1.020 |
| Long-term debt | 0 | 0 | 1.069 | 1.109 | 942 | 627 | 464 | 246 | 271 |
| Short-term debt | 2.773 | 4.859 | 3.462 | 4.851 | 4.209 | 4.507 | 6.694 | 8.989 | 7.580 |
| Total debt | 2.773 | 4.859 | 4.531 | 5.960 | 5.151 | 5.133 | 7.158 | 9.235 | 7.851 |
EBITDA margin
-33.1%
This company
15.8%
Market median
-309% vs market
20172024
Equity ratio
-14.8%
This company
38.2%
Market median
-139% vs market
20172024
Return on equity
-221117500.0%
This company
18.4%
Market median
-1201725643% vs market
20172024
Net profit margin
-35.1%
This company
8.1%
Market median
-533% vs market
20172024
Asset turnover
0.91×
This company
1.12×
Market median
+19% vs market
20172024
Debt / equity
7.74×
This company
0.62×
Market median
-1148% vs market
20172024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-07-01 – 2022-12-31
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-02-01 – 2017-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JT Management | Management | 2016 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2023 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
TJ-Imaging Holding ApS | Company | 100.0% | 100.0% | 2025 |
DuMed A/S | Company | 33.3% | 33.3% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
TJ-Imaging Holding ApS
TJ-Imaging ApS Board members of TJ-Imaging ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johanna Theresa Sørensen | Management | 0 companies |
| Lars Laustsen Gleerup | Board of Directors | 0 companies |
| Jan Borup Sørensen | Chairman | 0 companies |
| Thomas Emborg Kreutzfeldt | Board of Directors | 0 companies |